Should you worry about the compensation of the CEO of AngioDynamics, Inc. (NASDAQ: ANGO)?

0
67
Ricky Gervais talks hosting the Golden Globes for the fifth time in The Hollywood Reporter. (Photo: The Hollywood Reporter)

[ad_1]

<p class = "Canvas Atom Canvas Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Jim Clemmer was the CEO of AngioDynamics, Inc. (NASDAQ: ANGO) since 2016. This report first examines the amount of CEO compensation compared to CEO compensation for companies of similar size. Then we take a look at a snapshot of the company's growth. Finally, as a second performance indicator, we will look at the returns that shareholders have made in recent years. This process should give us an idea of ​​how fairly the CEO is being paid. "Data-reactid =" 27 "> Jim Clemmer has been the CEO of AngioDynamics, Inc. (NASDAQ: ANGO) since 2016. This report will initially review English: emagazine.credit-suisse.com/app/art … = The amount of CEO compensation compared to CEO compensation for companies of similar size This process is intended to give us an idea of ​​how fairly the CEO is paid.

<p class = "canvas-atom canvas-text Mb (1,0em) Mb (0) – sm Mt (0,8em) – sm" type = "text" content = " Check out our latest analysis for AngioDynamics "data-reactid =" 28 "> Check out our latest analysis for AngioDynamics

How does Jim Clemmer's compensation compare to comparable companies?

According to our data, AngioDynamics, Inc. had a market cap of $ 620 million and total annual compensation for the CEO of $ 3.0 million for the year to May 2019, at the time of writing. We believe total compensation is more important, but we do the CEO’s salary is lower at $ 687,000. It is important that there can be obstacles to performance that relate to the unpaid component of the total remuneration. We surveyed companies with market caps from $ 400 million to $ 1.6 billion and found that the average total CEO compensation for this group was $ 2.5 million.

So Jim Clemmer receives an amount similar to the median CEO compensation for the companies we looked at. This doesn't tell us much, but when we look at the performance of the actual business, we get a useful context.

The following graphic shows how the CEO's compensation at AngioDynamics has changed from year to year.

NasdaqGS: ANGO CEO Compensation, January 4, 2020

Is AngioDynamics, Inc. growing?

Over the past three years, AngioDynamics, Inc. has increased earnings per share (EPS) by an average of 42% per year (using a best match line). Sales increased by 14% compared to the previous year.

<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Overall, this is a positive result for the shareholders Es It's also good to see that the company has seen decent revenue growth in recent years, suggesting that the business is healthy and growing This free visual representation of what analysts expect for the futureEmagazine.credit-suisse.com/app/art…1007 & lang = DE Overall, this is a positive result for the shareholders, which shows that the company has improved in recent years. It could be important to review this free visual representation of what analysts expect for the future.

Was AngioDynamics, Inc. a good investment?

Since shareholders would have lost about 1.6% in three years, some AngioDynamics, Inc. shareholders would certainly feel negative emotions. It could therefore be annoying for shareholders if the CEO were paid generously.

In total…

Jim Clemmer, like most CEOs, is paid by companies of similar size.

<p class = "Canvas Atom Canvas Text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "We would say the company can boast of its growth Earnings per share, but the return for the past three years has been too low. We would be surprised if shareholders saw a wage increase for the CEO, but we would stop not saying their remuneration was too generous. You may want compensation Check if Insider is buying or selling AngioDynamics stocks (free trial)."data-reactid =" 52 "> We would say that the company can shine with its EPS growth, but we believe that the returns of the past three years have not been sufficient and we would be surprised if shareholders expect a wage increase Regardless of your assessment of remuneration, you should check whether Insider buy or sell AngioDynamics shares (free trial).

<p class = "canvas-atom canvas-text Mb (1,0em) Mb (0) – sm Mt (0,8em) – sm" type = "text" content = "Important note: AngioDynamics may not be the best stock to buy. You could find something better in the This list of interesting companies with high ROE and low debt. "data-reactid =" 53 ">Important note: AngioDynamics may not be the best stock to buy. You could find something better in this list of interesting companies with high ROE and low debt.

<p class = "canvas-atom canvas-text Mb (1,0em) Mb (0) – sm Mt (0,8em) – sm" type = "text" content = "If you discover an error that justifies a correction, please contact the editorial team at editorial-team@simplywallst.com, This article from Simply Wall St is general in nature. It is not a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Simply Wall St has no position in the stocks mentioned.

We strive to provide you with long-term, focused research analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or quality material. Thank you for reading."data-reactid =" 54 ">If you discover an error that justifies a correction, please contact the editorial team at editorial-team@simplywallst.com. This article from Simply Wall St is general in nature. It is not a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Simply Wall St has no position in the stocks mentioned.

We strive to provide you with long-term, focused research analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or quality material. Thank you for reading.